These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia. Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yolken R. Schizophr Res; 2012 Jan; 134(1):83-8. PubMed ID: 22048011 [Abstract] [Full Text] [Related]
3. Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder. Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Cole S, Krivogorsky B, Yolken RH. Biol Psychiatry; 2004 Mar 15; 55(6):588-93. PubMed ID: 15013827 [Abstract] [Full Text] [Related]
4. Assessment of cognitive impairment in HSV-1 positive schizophrenia and bipolar patients: Systematic review and meta-analysis. Tucker JD, Bertke AS. Schizophr Res; 2019 Jul 15; 209():40-47. PubMed ID: 30639164 [Abstract] [Full Text] [Related]
8. Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample. Yolken RH, Torrey EF, Lieberman JA, Yang S, Dickerson FB. Schizophr Res; 2011 May 15; 128(1-3):61-5. PubMed ID: 21353483 [Abstract] [Full Text] [Related]
16. Effects of tobacco smoking on neuropsychological function in schizophrenia in comparison to other psychiatric disorders and non-psychiatric controls. Morisano D, Wing VC, Sacco KA, Arenovich T, George TP. Am J Addict; 2013 Jan 15; 22(1):46-53. PubMed ID: 23398226 [Abstract] [Full Text] [Related]
17. Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder. Smith RC, Lindenmayer JP, Davis JM, Cornwell J, Noth K, Gupta S, Sershen H, Lajtha A. Schizophr Res; 2009 May 15; 110(1-3):149-55. PubMed ID: 19251401 [Abstract] [Full Text] [Related]
18. Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status. Dickerson F, Boronow JJ, Stallings C, Origoni AE, Cole SK, Yolken RH. Psychiatry Res; 2004 Nov 30; 129(1):45-53. PubMed ID: 15572184 [Abstract] [Full Text] [Related]
19. Differential impairment of social cognition factors in bipolar disorder with and without psychotic features and schizophrenia. Thaler NS, Allen DN, Sutton GP, Vertinski M, Ringdahl EN. J Psychiatr Res; 2013 Dec 30; 47(12):2004-10. PubMed ID: 24112946 [Abstract] [Full Text] [Related]
20. Neuropsychological functioning predicts community outcomes in affective and non-affective psychoses: a 6-month follow-up. Lewandowski KE, Cohen BM, Keshavan MS, Sperry SH, Ongür D. Schizophr Res; 2013 Aug 30; 148(1-3):34-7. PubMed ID: 23791391 [Abstract] [Full Text] [Related] Page: [Next] [New Search]